Siloam International Hospitals Tbk PT Financials

Market Capitalization €2.26 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	13.10
Forward PE
Price to Sales TTM	€0.00
Price to Book MRQ	€0.00
Enterprise to Revenue	0.04
Enterprise to EBITDA	0.19

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	8.57%
Operating Margin	23.88%
Return on Assets TTM	10.65%
Return on Equity TTM	13.82%

Income Statement

Revenue TTM	€704,858,413
Revenue per Share TTM	€918.06
Quarterly Revenue Growth	13.80%
Gross Profit TTM	€271,639,735
EBITDA	€2,641,034,000,000
Net Income to Common TTM	€60,418,924
Diluted EPS TTM	€92.92
Quarterly Earnings Growth YoY	18.50%

Balance Sheet

Total Cash MRQ	€50,022,159
Total Cash per Share MRQ	€65.19
Total Debt MRQ	€
Total Debt to Equity MRQ	13.78
Current Ratio MRQ	0.97
Book Value per Share MRQ	€609.51

Cash Flow

Operating Cash Flow TTM	€145,470,134
Levered Free Cash Flow TTM	€39,486,602

2LS Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	12,982,200,320
Float Shares	433,866,621
Avg 10 Volume	214
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	90.87%
% Held by Institutions	4.51%

Stock Price Summary

Beta	0.14
Fifty Two Week Low	€0.12
Fifty Two Week High	€0.19
Fifty Two Week Change	22.56%
Day 50 MA	€0.17
Day 200 MA	€0.16

Dividends and Splits

Forward Annual Dividend Rate	€80.00
Forward Annual Dividend Yield	48780.49%
Trailing Annual Dividend Rate	€20.00
Trailing Annual Dividend Yield	12195.12%
Payout Ratio	26.45%
Dividend Date
Ex Dividend Date	2024-06-10
Last Split Factor
Last Split Date	2022-04-08